Finally, driver gene analysis of the immune types revealed that IDH1, IDH2, and PLCH2 are the major driver genes for glioma, clearly suggesting that they may be potential targets for mRNA vaccines. The gene discussed is IDH1; the disease is central nervous system cancer.